Publication:
Seasonal upsurge of pneumococcal meningitis in the Central African Republic [version 2; peer review: 2 approved, 1 approved with reservations]

dc.contributor.authorThomas Crellenen_US
dc.contributor.authorV. Bhargavi Raoen_US
dc.contributor.authorTurid Pieningen_US
dc.contributor.authorJoke Zeydneren_US
dc.contributor.authorM. Ruby Siddiquien_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherMédecins Sans Frontières Operational Centre Amsterdamen_US
dc.contributor.otherMédecins Sans Frontières (MSF)en_US
dc.contributor.otherMédecins Sans Frontièresen_US
dc.date.accessioned2020-01-27T07:57:07Z
dc.date.available2020-01-27T07:57:07Z
dc.date.issued2019-01-01en_US
dc.description.abstract© 2019 Crellen T et al. A high incidence of bacterial meningitis was observed in the Central African Republic (CAR) from December 2015 to May 2017 in three hospitals in the northwest of the country that are within the African meningitis belt. The majority of cases were caused by Streptococcus pneumoniae (249/328; 75.9%), which occurred disproportionately during the dry season (November-April) with a high case-fatality ratio of 41.6% (95% confidence interval [CI] 33.0, 50.8%). High rates of bacterial meningitis during the dry season in the meningitis belt have typically been caused by Neisseria meningitidis (meningococcal meningitis), and our observations suggest that the risk of contracting S. pneumoniae (pneumococcal) meningitis is increased by the same environmental factors. Cases of meningococcal meningitis (67/328; 20.4%) observed over the same period were predominantly group W and had a lower case fatality rate of 9.6% (95% CI 3.6, 21.8%). Due to conflict and difficulties in accessing medical facilities, it is likely that the reported cases represented only a small proportion of the overall burden. Nationwide vaccination campaigns in the CAR against meningitis have been limited to the use of MenAfriVac, which targets only meningococcal meningitis group A. We therefore highlight the need for expanded vaccine coverage to prevent additional causes of seasonal outbreaks.en_US
dc.identifier.citationWellcome Open Research. Vol.3, (2019)en_US
dc.identifier.doi10.12688/wellcomeopenres.14868.2en_US
dc.identifier.issn2398502Xen_US
dc.identifier.other2-s2.0-85065655992en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/50377
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85065655992&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.subjectMedicineen_US
dc.titleSeasonal upsurge of pneumococcal meningitis in the Central African Republic [version 2; peer review: 2 approved, 1 approved with reservations]en_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85065655992&origin=inwarden_US

Files

Collections